<?xml version="1.0" encoding="UTF-8"?>
<p>In the past few weeks a number of clinical trials have been initiated to investigate the efficacy of remdesivir, chloroquine, and other substances against COVID-19 (
 <xref rid="T1" ref-type="table">table 1</xref>)
 <italic>.</italic> Since no specific treatment for this infection has yet been established, and in the light of previous experience, some of these trials are planned as placebo-controlled double-blind studies. They differ with regard to their inclusion criteria, e.g., severity of disease and time from diagnosis to randomization. The first trials are expected to reach completion by the end of April 2020. Details of all these studies can be found at 
 <ext-link ext-link-type="uri" xlink:href="www.clinicaltrials.gov" xmlns:xlink="http://www.w3.org/1999/xlink">www.clinicaltrials.gov</ext-link>.
</p>
